Alerts will be sent to your verified email
Verify Email
MARKSANS
|
Marksans Pharma
|
FDC
|
Strides Pharma Scien
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
17.57 % | 13.66 % | 23.7 % |
|
5yr Avg Net Profit Margin
|
14.56 % | 16.24 % | 12.9 % |
|
Price to Book
|
3.09 | 3.26 | 3.24 |
|
P/E
|
21.74 | 27.65 | 22.78 |
|
5yr Avg Cash Conversion Cycle
|
71.65 Days | -14.0 Days | -51.45 Days |
|
5yr Average Interest Coverage Ratio
|
38.03 | 90.41 | 0.72 |
|
5yr Avg ROCE
|
21.95 % | 14.95 % | 10.5 % |
|
5yr Avg Operating Profit Margin
|
20.32 % | 18.97 % | 12.17 % |
|
5 yr average Debt to Equity
|
0.02 | 0.0 | 1.01 |
|
5yr CAGR Net Profit
|
10.03 % | -2.41 % | 68.01 % |
|
5yr Average Return on Assets
|
13.19 % | 8.73 % | 10.97 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.87 % | 69.66 % | 28.3 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 50.1 % |
|
Change in Promoter Holding (3 Yrs)
|
-4.38 % | 0.16 % | -2.07 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
2.6 % | 1.1 % | -0.99 % |
|
Marksans Pharma
|
FDC
|
Strides Pharma Scien
|
|---|